Cabergoline and cardiac failure 
Cabergoline and cardiac failure Patient Reports February 12, 2012
Cabergoline Side Effects Report #5006744-5
Cabergoline side effect was reported by a Physician from GERMANY on May 03, 2006. Female patient, 69 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cough, pericardial effusion, pericarditis. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5026989-8
Cabergoline side effect was reported by a Physician from GERMANY on May 30, 2006. Female patient, 69 years of age, weighting 147.7 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cough, foreign body trauma, myocarditis, pericardial effusion, pericarditis, thyroid gland scan abnormal, viral infection
. Cabergoline dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, CARVEDILOL. Patient recovered.Cabergoline Side Effects Report #4934700-1
Cabergoline side effect was reported by a Physician from SPAIN on Feb 20, 2006. Male patient, 74 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac failure, cardiac murmur, cardiac valve disease, cardiomegaly, dilatation atrial, gallop rhythm present, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4 MG (2 MG, 2 IN 1 D). Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4597248-2
Cabergoline side effect was reported by a Physician from on Feb 16, 2005. Male patient, 85 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: asthenia, cardiac disorder, cardiac failure, dyspnoea, pericardial effusion. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, DICLOFENAC, SPIRONOLACTONE, TORADEMIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4603279-6
Cabergoline side effect was reported by a Physician from on Feb 23, 2005. Male patient, 85 years of age, weighting 152.1 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure, dyspnoea, pericardial effusion. Cabergoline dosage: 4 + 6MG (4 MG) ORAL. During the same period patient was treated with MADOPAR, DICLOFENAC, SPIRONOLACTONE, TORSEMIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4603006-2
Cabergoline side effect was reported by a Physician from on Feb 18, 2005. Female patient, 77 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5551841-9
Cabergoline side effect was reported by a Physician from JAPAN on Nov 30, 2007. Male patient, 76 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, oedema. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5738139-0
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on May 02, 2008. Male patient, 76 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, mitral valve incompetence, mitral valve stenosis. Cabergoline dosage: unknown. During the same period patient was treated with PERGOLIDE MESYLATE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5653886-7
Cabergoline side effect was reported by a Physician from JAPAN on Feb 28, 2008. Male patient, 75 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure. Cabergoline dosage: unknown. During the same period patient was treated with GLYSENNID, SELEGILINE HYDROCHLORIDE, ACENALIN, FAMOTIDINE, SYMMETREL, ZONISAMIDE, MADOPAR. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5085990-9
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2006. Female patient, 74 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, disseminated intravascular coagulation, dyspnoea, mitral valve incompetence, oedema peripheral, pulmonary hypertension , pulmonary oedema, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient died.Cabergoline Side Effects Report #4696161-X
Cabergoline side effect was reported by a Pharmacist from on June 06, 2005. Male patient, 74 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anuria, blood pressure decreased, cardiac failure, condition aggravated, depressed level of consciousness, interstitial lung disease, mitral valve disease, respiratory arrest, respiratory failure. Cabergoline dosage: unknown. During the same period patient was treated with DROXIDOPA, NEODOPASOL, DEPAS IETIZOLAM), NAUZELIN, LASIX, LANIRAID. Patient was hospitalized. Patient died on 05/10/2005.Cabergoline Side Effects Report #4996295-6
Cabergoline side effect was reported by a Physician from SPAIN on Apr 27, 2006. Male patient, 73 years of age, weighting 213.8 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic elongation, aortic valve incompetence, aortic valve sclerosis, atrial fibrillation , cardiac failure, cardiac murmur, cardiomegaly. Cabergoline dosage: 3 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4617892-3
Cabergoline side effect was reported by a Physician from on Mar 09, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, cardiac failure, dyskinesia, dyspnoea exertional, oedema peripheral, pleural effusion, weight increased. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4645346-7
Cabergoline side effect was reported by a Physician from on Apr 11, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, aortic valve incompetence, blood pressure systolic increased, cardiac failure, cardiomegaly, dilatation atrial, dyspnoea exertional, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 2 MG , ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4658886-1
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure systolic increased, cardiac failure, mitral valve prolapse, oedema peripheral, pleural effusion, pulmonary valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4671037-2
Cabergoline side effect was reported by a Physician from on May 09, 2005. Female patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure. Cabergoline dosage: 4 MG (4 MG ONCE DAILY) ORAL. During the same period patient was treated with EC DOPRAL. Patient died on 05/08/2005.Cabergoline Side Effects Report #4781130-1
Cabergoline side effect was reported by a Physician from SPAIN on Sept 14, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, cardiac failure. Cabergoline dosage: 2 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4874914-2
Cabergoline side effect was reported by a Physician from SPAIN on Dec 28, 2005. Male patient, 72 years of age, weighting 213.8 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic disorder, aortic valve incompetence, aortic valve sclerosis, atrial fibrillation , cardiac failure, cardiac murmur, cardiomegaly. Cabergoline dosage: 3 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5304905-9
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on Apr 11, 2007. Male patient, 71 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac failure, cardiac valve disease, constipation , dyspnoea paroxysmal nocturnal, haemodynamic instability, ileus, megacolon, neuroleptic malignant syndrome. Cabergoline dosage: unknown. During the same period patient was treated with SELEGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4681935-1
Cabergoline side effect was reported by a Physician from on May 23, 2005. Female patient, 71 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, myocardial infarction. Cabergoline dosage: unknown. During the same period patient was treated with EC DOPRAL, ALFACALCIDOL. Patient died on 05/09/2005.Cabergoline Side Effects Report #4690022-8
Cabergoline side effect was reported by a Physician from on May 31, 2005. Female patient, 71 years of age, was diagnosed with parkinson's disease
, osteoporosis , cardiac failure and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, myocardial infarction. Cabergoline dosage: unknown. During the same period patient was treated with EC DOPARL, ALFACALCIDOL, FUROSEMIDE. Patient died on 05/09/2005.Cabergoline Side Effects Report #4699650-7
Cabergoline side effect was reported by a Physician from on June 14, 2005. Female patient, 70 years of age, weighting 136.7 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic atherosclerosis, aortic valve disease mixed, aortic valve incompetence, cardiac failure. Cabergoline dosage: 2 MG (DAILY), ORAL. During the same period patient was treated with MANIDON, ADIRO, SINEMET, SEROXAT NOVO NORDISK. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4939584-3
Cabergoline side effect was reported by a Physician from FINLAND on Feb 27, 2006. Female patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, atelectasis, cardiac failure, crohn's disease , dehydration, fatigue, hypotonia, infection . Cabergoline dosage: 5 MG (DAILY), ORAL. During the same period patient was treated with DUREKAL, MOVICOL, MADOPAR, EFFORTIL, VESIX, TENOX, TRIMOPAN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4942849-2
Cabergoline side effect was reported by a Physician from FINLAND on Feb 27, 2006. Female patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, atelectasis, cardiac failure, crohn's disease , dehydration, fatigue, hypotonia, infection . Cabergoline dosage: 5 MG (DAILY), ORAL. During the same period patient was treated with DUREKAL, MOVICOL, MADOPAR, EFFORTIL, VESIX, TENOX, TRIMOPAN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4629438-4
Cabergoline side effect was reported by a Physician from on Mar 24, 2005. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aortic valve incompetence, cardiac failure, cardiac valve disease, cardiomegaly, condition aggravated, echocardiogram abnormal, mitral valve incompetence, palpitations. Cabergoline dosage: unknown. During the same period patient was treated with PERGOLIDE MESYLATE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4596675-7
Cabergoline side effect was reported by a Physician from on Feb 14, 2005. Female patient, 68 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: amaurosis fugax, aortic injury, aortic valve incompetence, cardiac failure, condition aggravated, left ventricular failure, mitral valve incompetence, orthopnoea, parkinson's disease . Cabergoline dosage: 4 MG (4 MG, QD), ORAL. During the same period patient was treated with MADOPAR, MESALAMINE, FUROSEMIDE, AMILORIDE W, LEVODOPA W, CLOPIDOGREL BISULPHATE, CITALOPRAM, PAROXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4920575-3
Cabergoline side effect was reported by a Health Professional from SWEDEN on Feb 06, 2006. Male patient, 68 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, dementia , dilatation atrial, hallucination, hypotension, mitral valve incompetence, orthostatic hypotension, pulmonary arterial pressure increased. Cabergoline dosage: 8 MG (1 D), ORAL. During the same period patient was treated with ARICEPT, EMCONCOR, MADOPARK, MADOPARK QUICK, EXELON, EDRONAX, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5065721-9
Cabergoline side effect was reported by a Physician from JAPAN on July 12, 2006. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac failure, cardiomegaly, cardiomyopathy , pleural effusion, pneumonia , pulmonary congestion, supraventricular tachycardia. Cabergoline dosage: 3 MG (1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5072976-3
Cabergoline side effect was reported by a Physician from JAPAN on July 24, 2006. Male patient, 64 years of age, weighting 127.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomegaly, congestive cardiomyopathy, pleural effusion, pneumonia , pulmonary congestion, supraventricular tachycardia. Cabergoline dosage: 3 MG (1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4987994-0
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Apr 19, 2006. Male patient, 58 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, cardiac procedure complication, mitral valve incompetence, mitral valve sclerosis, tricuspid valve incompetence, tricuspid valve sclerosis. Cabergoline dosage: 6 MG (6 MG, 1 D), ORAL. During the same period patient was treated with SINEMET, ELDEPRYL, SIMVASTATIN, ODRIK, SPIRONOLACTONE, CORDARONE, FUROSEMIDE, DIMITONE. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4710055-2
Cabergoline side effect was reported by a Physician from ITALY on June 23, 2005. Female patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, mitral valve incompetence. Cabergoline dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with MANTADAN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4710522-1
Cabergoline side effect was reported by a Physician from ITALY on June 27, 2005. Female patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, cardiac failure, mitral valve disease. Cabergoline dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with MANTADAN, SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5086014-X
Cabergoline side effect was reported by a Pharmacist from SPAIN on Aug 07, 2006. Female patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: 4 MG (1 MG), ORAL. During the same period patient was treated with SELEGILINE, LEVODOPA, BENSERAZIDE, CARBIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5104134-8
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Aug 28, 2006. Female patient, 41 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, mitral valve incompetence, mitral valve stenosis, obstruction, obstructive airways disorder, total lung capacity decreased. Cabergoline dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.Cabergoline Side Effects Report #5584636-0
Cabergoline side effect was reported by a Physician from JAPAN on Dec 27, 2007. Female patient, weighting 81.57 lb, was diagnosed with parkinson's disease
, insomnia, constipation , gastritis, neurosis and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac valve disease, interstitial lung disease. Cabergoline dosage: unknown. During the same period patient was treated with MENESIT, SYMMETREL, AMOBAN, MAGNESIUM OXIDE, MARZULENE S, DEPAS. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4596621-6
Cabergoline side effect was reported by a Physician from on Feb 14, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic stenosis, cardiac failure. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5532464-4
Cabergoline side effect was reported by a Physician from JAPAN on Nov 22, 2007. Male patient, weighting 176.4 lb, was diagnosed with depression
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, cardiac valve disease, congestive cardiomyopathy, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, TRYPTANOL, RIVOTRIL, EPADEL, ALOSITOL, ROHYPNOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5529707-X
Cabergoline side effect was reported by a Pharmacist from JAPAN on Nov 21, 2007. Male patient, 76 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, oedema. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #5526903-2
Cabergoline side effect was reported by a Physician from JAPAN on Nov 15, 2007. Female patient, 75 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, interstitial lung disease. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5298356-3
Cabergoline side effect was reported by a Physician from ITALY on Mar 27, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, mitral valve incompetence. Cabergoline dosage: unknown. Patient recovered.